Atenolol and chlorthalidone and Spironolactone and hydrochlorothiazide interaction
Atenolol and chlorthalidone and Spironolactone and hydrochlorothiazide: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.
Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.
What the FDA labels say
From the Spironolactone and hydrochlorothiazide label · effective 2026-02-10
Concomitant administration of spironolactone and hydrochlorothiazide tablets with the following drugs or potassium sources may lead to severe hyperkalemia: • other potassium-sparing diuretics • ACE inhibitors • angiotensin II receptor antagonists • aldosterone blockers • non-steroidal anti-inflammatory drugs (NSAIDs), e.g., indomethacin • heparin and low molecular…
Thiazides may add to or potentiate the action of other antihypertensive drugs.
From the Atenolol and chlorthalidone label · effective 2025-09-22
Because of its relative beta 1 -selectivity, however, atenolol and chlorthalidone may be used with caution in patients with bronchospastic disease who do not respond to or cannot tolerate, other antihypertensive treatment.
Drug Interactions Atenolol and chlorthalidone may potentiate the action of other antihypertensive agents used concomitantly.
Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity.
Other Precautions In patients receiving thiazides, sensitivity reactions may occur with or without a history of allergy or bronchial asthma.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.